StockData
CytoDyn Inc. logo

CytoDyn Inc. (CYDY) stock

CYDYOTCPharmaceutical PreparationsFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 14, 2026Score 4/30
$0.25+0.02 (+9.53%)

Close on Oct 19, 2026Market cap $345.56MP/E –Yield –

CytoDyn ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

CytoDyn's ebitda for the twelve months ending Aug 31, 2026 was -$40.18M. For fiscal 2026 it was -$38.56M, down 498.4% from the year before. The highest annual figure on record is $9.68M in fiscal 2025.

Annual ebitda

PeriodPeriod endValueChange
FY2026May 31, 2026-$38.56M-498.4%
FY2025May 31, 2025$9.68M–
FY2024May 31, 2024-$18.03M–
FY2023May 31, 2023-$40.40M–
FY2022May 31, 2022-$144.62M–
FY2021May 31, 2021-$102.80M–
FY2020May 31, 2020-$72.61M–
FY2019May 31, 2019-$54.61M–
FY2018May 31, 2018-$45.56M–
FY2017May 31, 2017-$26.96M–
FY2016May 31, 2016-$20.81M–
FY2015May 31, 2015-$19.24M–
FY2014May 31, 2014-$7.76M–
FY2013May 31, 2013-$7.77M–
FY2012May 31, 2012-$7.45M–
FY2011May 31, 2011-$3.70M–

Quarterly ebitda

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Aug 31, 2026-$6.56M–
Q4 FY2026CQ2 2026May 31, 2026-$5.64M–
Q3 FY2026CQ1 2026Feb 28, 2026-$6.30M–
Q2 FY2026CQ4 2025Nov 30, 2025-$21.68M–
Q1 FY2026CQ3 2025Aug 31, 2025-$4.94M-122.0%
Q4 FY2025CQ2 2025May 31, 2025-$5.06M–
Q3 FY2025CQ1 2025Feb 28, 2025-$4.00M–
Q2 FY2025CQ4 2024Nov 30, 2024-$3.70M–
Q1 FY2025CQ3 2024Aug 31, 2024$22.44M–
Q4 FY2024CQ2 2024May 31, 2024-$6.63M–
Q3 FY2024CQ1 2024Feb 29, 2024-$3.41M–
Q2 FY2024CQ4 2023Nov 30, 2023-$3.39M–
Q1 FY2024CQ3 2023Aug 31, 2023-$4.60M–
Q2 FY2023CQ4 2022Nov 30, 2022-$23.11M–
Q1 FY2023CQ3 2022Aug 31, 2022-$9.61M–
Q4 FY2022CQ2 2022May 31, 2022-$78.92M–
Q3 FY2022CQ1 2022Feb 28, 2022-$19.27M–
Q2 FY2022CQ4 2021Nov 30, 2021-$25.07M–
Q1 FY2022CQ3 2021Aug 31, 2021-$21.36M–
Q4 FY2021CQ2 2021May 31, 2021-$23.36M–
Q3 FY2021CQ1 2021Feb 28, 2021-$30.27M–
Q2 FY2021CQ4 2020Nov 30, 2020-$24.00M–
Q1 FY2021CQ3 2020Aug 31, 2020-$25.06M–
Q4 FY2020CQ2 2020May 31, 2020-$27.32M–
Q3 FY2020CQ1 2020Feb 29, 2020-$21.57M–
Q2 FY2020CQ4 2019Nov 30, 2019-$11.62M–
Q1 FY2020CQ3 2019Aug 31, 2019-$12.10M–
Q4 FY2019CQ2 2019May 31, 2019-$13.31M–
Q3 FY2019CQ1 2019Feb 28, 2019-$12.37M–
Q2 FY2019CQ4 2018Nov 30, 2018-$15.53M–
Q1 FY2019CQ3 2018Aug 31, 2018-$13.40M–
Q4 FY2018CQ2 2018May 31, 2018-$11.11M–
Q3 FY2018CQ1 2018Feb 28, 2018-$14.05M–
Q2 FY2018CQ4 2017Nov 30, 2017-$10.69M–
Q1 FY2018CQ3 2017Aug 31, 2017-$9.72M–
Q4 FY2017CQ2 2017May 31, 2017-$7.71M–
Q3 FY2017CQ1 2017Feb 28, 2017-$7.93M–
Q2 FY2017CQ4 2016Nov 30, 2016-$6.06M–
Q1 FY2017CQ3 2016Aug 31, 2016-$5.27M–

More CytoDyn figures

See a number that looks wrong?